Medicare Enrolled

Dr. Scott Ferrara, D.O.

Pulmonary Disease · Lodi, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
160 ESSEX ST STE 103, Lodi, NJ 07644
5519961370
In practice since 2014 (12 years)
NPI: 1710305339 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ferrara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferrara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ferrara

Dr. Scott Ferrara is a pulmonary disease specialist in Lodi, NJ, with 12 years of NPI registration. Based on federal Medicare data, Dr. Ferrara performed 1,854 Medicare services across 1,085 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ferrara received a total of $18,310 from 35 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ferrara is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 37% volume in NJ $18,310 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,854
Medicare services
Top 37% in NJ for pulmonary disease
1,085
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
696 $69 $241
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
363 $109 $434
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
135 $74 $309
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
104 $104 $354
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
102 $141 $564
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
82 $34 $139
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
82 $37 $158
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
82 $47 $212
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
75 $110 $440
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
59 $147 $628
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
32 $91 $384
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
18 $94 $1,183
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
12 $87 $902
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
12 $11 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,310
Total received (2018-2024)
Avg $3,052/year across 6 years
Top 6% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,054 (60.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,256 (39.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,788
2023
$3,713
2022
$1,659
2021
$2,859
2020
$256
2018
$35

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$6,794
GlaxoSmithKline, LLC.
$469
Pulmonx Corporation
$466
Inspire Medical Systems, Inc.
$267
Mylan Specialty L.P.
$266
Amgen Inc.
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Actelion Pharmaceuticals US, Inc.
$169
Insmed, Inc.
$161
GENZYME CORPORATION
$98
INTUITIVE SURGICAL, INC.
$89
Regeneron Healthcare Solutions, Inc.
$85
Philips North America LLC
$84
SANOFI-AVENTIS U.S. LLC
$80
Mallinckrodt Hospital Products Inc.
$60
Novartis Pharmaceuticals Corporation
$59
Takeda Pharmaceuticals U.S.A., Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$41
Grifols USA, LLC
$38
HARMONY BIOSCIENCES LLC
$33
United Therapeutics Corporation
$33
Merck Sharp & Dohme LLC
$31
ANI Pharmaceuticals, Inc.
$15
Top 3 companies account for 79.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$8,784
GlaxoSmithKline, LLC.
$2,135
Pulmonx Corporation
$1,772
Intuitive Surgical, Inc.
$645
Amgen Inc.
$622
Boehringer Ingelheim Pharmaceuticals, Inc.
$548
Mylan Specialty L.P.
$544
Insmed, Inc.
$447
GENZYME CORPORATION
$402
Inspire Medical Systems, Inc.
$267
Actelion Pharmaceuticals US, Inc.
$263
Grifols USA, LLC
$263
Regeneron Healthcare Solutions, Inc.
$220
Novartis Pharmaceuticals Corporation
$188
Philips Electronics North America Corporation
$145
SANOFI-AVENTIS U.S. LLC
$135
Acerta Pharma LLC
$117
Mallinckrodt Hospital Products Inc.
$105
INTUITIVE SURGICAL, INC.
$89
Philips North America LLC
$84
Takeda Pharmaceuticals U.S.A., Inc.
$73
Bayer Healthcare Pharmaceuticals Inc.
$72
United Therapeutics Corporation
$61
Merck Sharp & Dohme LLC
$46
Teva Pharmaceuticals USA, Inc.
$42
HARMONY BIOSCIENCES LLC
$33
Harmony Biosciences LLC
$33
ANI Pharmaceuticals, Inc.
$32
Baxter Healthcare
$30
Exeltis, USA Inc.
$29
Merck Sharp & Dohme Corporation
$24
Genentech USA, Inc.
$18
Axsome Therapeutics, Inc.
$17
PFIZER INC.
$14
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 69.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANDEXXA · ARALAST · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BREZTRI · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · ELIQUIS · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · INSPIRE · NUCALA · OFEV · OPSUMIT · PULMICORT RESPULES · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · WAKIX · WINREVAIR · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pulmonary disease in NJ.

Looking for a pulmonary disease specialist in Lodi?
Compare pulmonary diseases in the Lodi area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
647
Per 100K population
67.8
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ferrara is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 6% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ferrara experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Ferrara performed 696 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ferrara receive payments from pharmaceutical companies?
Yes. Dr. Ferrara received a total of $18,310 from 35 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ferrara's costs compare to other pulmonary diseases in Lodi?
Dr. Ferrara's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ferrara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →